[1]邹欣欣,王瑞青,霍记平,等.医护人员对更年期及绝经期激素治疗认知情况调查[J].中国计划生育和妇产科,2019,(7):86-89.
　ZOU Xin-xin,WANG Rui-qing,HUO Ji-ping,et al.Survey of cognition of menopause and menopausal hormone treatment in medical staff[J].Chinese Journal of Family Planning & Gynecotokology,2019,(7):86-89.
点击复制

医护人员对更年期及绝经期激素治疗认知情况调查
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年7期
页码:
86-89
栏目:
论著与临床
出版日期:
2019-06-25

文章信息/Info

Title:
Survey of cognition of menopause and menopausal hormone treatment in medical staff
作者:
邹欣欣1; 王瑞青2;  霍记平3;  李丽君4;  许英霞5;  张丽梅1; 高辉1*
首都医科大学附属北京天坛医院，1.妇产科；2.健康管理中心；3.药学部；4.心理科；5.临床营养科
Author(s):
ZOU Xin-xin1;  WANG Rui-qing2;  HUO Ji-ping3;  LI Li-jun4;  XU Ying-xia5;  ZHANG Li-mei1;  GAO Hui1*
1.Department of Obstetrics and Gynaecology；2.Health Management Center；3.Department of Pharmacy；4.Department of Psychology；5.Department of Clinical Nutrition, Capital Medical University Affiliated Beijing Tiantan Hospital, Beijing 100070,P.R.China
关键词:
更年期; 绝经; 激素治疗; 横断面调查
Keywords:
climateric; menopause; MHT; cross-section study
分类号:
R 711.5
摘要:
目的了解北京天坛医院在职女职工对更年期及绝经期激素治疗（menopause hormone treatment，MHT）的认知情况。方法2018年3月1日至3月15日向医院全体女职工下发“问卷星”调查问卷并收回。内容包括调查对象的一般情况、更年期知识及MHT，采用SPSS 170 软件进行统计分析。结果① 共发放问卷2 164份，回收有效问卷1 968份，回收率9094 %。② 女职工对更年期的关注度与年龄和家庭人均收入相关，与文化程度、教育背景不相关。46～55岁的女职工关注度最高。家庭人均月收入<5 000元组对更年期的关注度显著低于收入更高组。大部分被调查者知道绝经增加心血管事件风险和增加骨质疏松／骨折风险，仅2998 %认为更年期需要MHT，1880 %希望了解MHT。有医学教育背景者及文化程度高者知晓率高。③ 有更年期症状的女职工中，接受或曾经接受过MHT的占1594 %。是否接受MHT，与文化程度、教育背景、人均收入均不相关。拒绝接受MHT的主要原因是“更年期是自然生理过程，应该顺其自然”和“性激素治疗增加癌症风险”。结论女性医护人员对更年期及MHT的认知仍需提高。即使是接受过正规医学教育的工作人员亦受到传统文化和社会舆论的深刻影响。应加强相关知识的宣传和普及。
Abstract:
Objective To investigate the knowledge of climacteric and menopausal hormone therapy (MHT) among female employees in Beijing Tiantan Hospital. MethodsA questionnaire was sent to all female employees in the hospital from March 1st to March 15th,2018. The content includes general situation, menopause and MHT knowledge of the respondents. The results were statistically analyzed using SPSS 170 software. Results ① A total of 2 164 questionnaires were distributed and 1 968 valid questionnaires were collected, with a recovery rate of 9094 %. ② The extent of female employees' concern of menopause was related to age and family percapita income, and was not related to education level and educational background. Female employees aged 46～55 concerned the most. The income group with family percapita income <5 000 RMB had significantly smaller percentage of respondents concerning about menopause than the higher income group. Most of the respondents knew that menopause increases the risk of cardiovascular events and of osteoporosis/bone fracture. Only 2998 % thought that MHT was needed for menopause, and 1880 % intent to know about MHT. Those with a background in medical education and those with a high degree of education presented a higher percentage of awareness. ③ Among the female employees with menopausal symptoms, 1594 % received or had received MHT. Whether or not to accept MHT was not related to the level of education, educational background, and percapita income. The main reasons for rejecting MHT were "menopause is a natural physiological process that women should let things take their own course "and "sex hormone therapy increases the risk of cancer." ConclusionFemale health care providers still need to improve their knowledge of climacteric and MHT. Even employees who have received formal medical education are deeply influenced by traditional culture and public opinion. The promotion and popularization of climacteric-related knowledge should be strengthened.

参考文献/References:

［1］国家统计局, 2015年国民经济和社会发展统计公报［EB/OL］, 2015. ［2］ROMERO-ORTUNO R, FOUWEATHER T, JAGGER C. Cross-national disparities in sex differences in life expectancy with and without frailty ［J］. Age and Ageing, 2014, 43(2): 222-228. ［3］李成福，王海涛，王勇，等．婚姻对老年人健康预期寿命影响的多状态研究 ［J］．老龄科学研究，2018，6（6）：38-44． ［4］刘勇，余剑波，马建军．“视频网站+问卷星+微信”组合在教学中的应用 ［J］.实验教学与仪器，2016，2（33）：45-47． ［5］DE ARRUDA A I, BACCARO L F, LUI-FILHO J F, et al. Factors associated with knowledge about menopause and hormone therapy in middle-aged Brazilian women ［J］. Menopause (New York, N.Y.), 2018, 25(7): 803-810. ［6］SHORT H. Changing the change ［J］. Post Reprod Health, 2015, 21(1): 34-36. ［7］WANG X, RAN S, YU Q. Optimizing quality of life in perimenopause: lessons from the East ［J］. Climacteric, 2019, 22(1, SI): 34-37. ［8］VELENTZIS L S, SALAGAME U, CANFELL K. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations ［J］. BMC Health Services Research, 2017, 17(1): 326. ［9］王一飞．制订具有中国特色的女性更年期健康促进规划 ［J］．中国新药与临床杂志，2018，37（9）：537-538． ［10］王彦洁，杨欣，赵旸，等．医护人员围绝经期情况调查 ［J］．中国妇产科临床杂志，2014，15（1）：25-28． ［11］GRAFFIGNA G, BARELLO S. Spotlight on the patient health engagement model (PHE model): a psychosocial theory to understand people's meaningful engagement in their own health care ［J］. Patient Preference and Adherence, 2018, 12: 1261-1271. ［12］LAFLEUR J, RILLAMAS-SUN E, COLN-EMERIC C S, et al. Fracture rates and bone density among post menopausal veteran and Non-Veteran women from the women's health initiative ［J］. The Gerontologist, 2016, 56(S1): S78-S90. ［13］SAUL S R, AGING K N, TRANSITION T M. And hormone replenishment therapy:retrieval of confidence and compliance ［J］. Annals of the New York Academy of Sciences, 2019, 1440(1): 5-22. ［14］ Simin J, Tamimi R, Lagergren J, et al. Menopausal hormone therapy and cancer risk: An overestimated risk?［J］ Eur J Cancer, 2017，84（7）: 60-68. ［15］KYVERNITAKIS I, KOSTEV K, HARS O, et al. Discontinuation rates of menopausal hormone therapy among postmenopausal women in the post-WHI study era ［J］. Climacteric, 2015, 18(5): 737-742. ［16］RAN S-y, YU Q, CHEN Y, et al. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study ［J］. Climacteric, 2017, 20(4): 391-396. ［17］ANAGNOSTIS P, PASCHOU S, KATSIKI N, et al. Menopausal hormone therapy and cardiovascular risk ［Z］, 2018. ［18］PINES A. Alzheimer's disease, menopause and the impact of the estrogenic environment ［J］. Climacteric, 2016, 19(5): 430-432. ［19］中华医学会妇产科学分会绝经学组．中国绝经管理与绝经激素治疗指南(2018) ［J］．协和医学杂志，2018，6（9）：19-32． ［20］ANAGNOSTIS E A. Menopausal hormone therapy(MHT):refining our understanding of MHT research,optimally applying results,and considering the future of MHT ［J］. Journal of Pharmacy Practice, 2012, 25(3): 324-330. ［21］WANG Yan-jie, YANG Xin, LI Xiao-dong, et al. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey ［J］. Menopause-The Journal of the North American Menopause Society, 2014, 21(11): 1190-1196.

相似文献/References:

[1]李青,王改珍.复方萘普生栓配伍米索前列醇用于绝经后取器80例[J].中国计划生育和妇产科,2010,(05):0.
　LI Qing,WANG Gai-zhen.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(7):0.
[2]曾莉琴,赖映华,徐利清,等.绝经后妇女取器术前宫颈准备3种方法效果比较[J].中国计划生育和妇产科,2010,(06):0.
[3]景秀,尹淑.米索前列醇不同给药途径用于绝经后妇女取器的临床研究[J].中国计划生育和妇产科,2011,(05):0.
　JING Xiu,YIN Shu ..[J].Chinese Journal of Family Planning & Gynecotokology,2011,(7):0.
[4]郁琦,魏代敏.绝经相关激素补充治疗的适应证及历史发展[J].中国计划生育和妇产科,2012,(05):0.
　YU Qi,WEI Dai-min.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(7):0.
[5]任慕兰,王艳,王丽平,等.绝经与认知功能障碍[J].中国计划生育和妇产科,2012,(05):0.
　REN Mu-lan,WANG YAN,WANG Li-ping.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(7):0.
[6]安黎明.卡前列甲酯栓用于绝经后妇女宫内节育器取出术的临床观察[J].中国计划生育和妇产科,2013,(04):0.
　AN Li-ming.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[7]张静,刘莉.天然孕酮对绝经期子宫内膜增厚的治疗效果评价[J].中国计划生育和妇产科,2013,(05):0.
　ZHANG Jin,LIU Li,Maternal Care Centre,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[8]范湘玲,刘燕,杨欣,等.围绝经期及绝经后妇女性生活现状及相关影响因素调查[J].中国计划生育和妇产科,2014,(09):0.
　FAN Xiang-Ling,LIU Yan,YANG Xin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[9]刘粉年.绝经后妇女阴道出血原因分析[J].中国计划生育和妇产科,2015,(02):0.
　LIU Fen-nian,The Family Planning Guidance Station of Baoying County,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(7):0.
[10]王声萍,张雅君,张红菱,等.武汉市围绝经期妇女压力性尿失禁患病率及影响因素的调查[J].中国计划生育和妇产科,2016,(04):0.
　WANG Sheng-ping,ZHANG Ya-jun,ZHANG Hong-ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(7):0.

更新日期/Last Update: 2019-07-25